Wednesday, February 10, 2010, 4:42pm SGT - The Singapore stock market closes in 18 minutes.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Chelsea Therapeutics International Ltd. (CHTP)

At 5:00AM SGT: 2.53 USD   0.00 (0.00%)  
 MORE ON CHTP 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 Chelsea Therapeutics Internatio (NCM:CHTP) Delayed quote dataEdit
Last Trade:2.53 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:2.53
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:6.67
Day's Range:N/A - N/A
52wk Range:1.27 - 7.51
Volume:0
Avg Vol (3m):394,181
Market Cap:84.76M
P/E (ttm):N/A
EPS (ttm):-0.94
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y 
Use Y! Toolbar to track stocks
 Add CHTP to Portfolio   Download Data

 HEADLINES 
•CHELSEA THERAPEUTICS INTERNATIONAL, LTD. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhib
EDGAR Online (Wed 2:29am)
•Chelsea Therapeutics Announces Advancements in Neurogenic Orthostatic Hypotension Registration Program
GlobeNewswire (Tue 8:30pm)
•How the Brokers Stack Up
at Barrons.com (Sat, Feb 6)
•Chelsea Therapeutics to Present at 12th Annual BIO CEO & Investor Conference
GlobeNewswire (Wed, Feb 3)
•[video] Trading Smallcap Biotech
at TheStreet.com (Mon, Feb 1)
•Insider Sells $8.3M Worth of Complete Production Svs
TheStreet.com (Fri, Jan 22)
•GenVec, Allied Defense: Early Volume Plays
at TheStreet.com (Tue, Jan 19)
•CHELSEA THERAPEUTICS INTERNATIONAL, LTD. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhib
EDGAR Online (Thu, Dec 17)
•StockPreacher Initiates Independent Research Coverage for Chelsea Therapeutics International Inc.
GlobeNewswire (Wed, Dec 16)
•Chelsea Therapeutics Granted Approval to Change the Primary Endpoint and Increase Enrollment in Droxidopa Pivotal Study 301
GlobeNewswire (Tue, Dec 15)
More Headlines for CHTP...
 ANALYST 
EPS Est (next year) (Dec-09) :-0.90
EPS Est (in 2 years) (Dec-10) :-1.02
Avg Rec (current)*:1.6
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Chelsea Therapeutics International, Ltd., a development stage pharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of various human diseases.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices